Stereotactic radiation therapy for liver metastases: factors affecting local control and survival.
Andratschke NHJ, Nieder C, Heppt F, Molls M, Zimmermann F (2015)
Publication Type: Journal article
Publication year: 2015
Journal
Book Volume: 10
Pages Range: 69
DOI: 10.1186/s13014-015-0369-9
Abstract
To report on outcome and toxicity of stereotactic body radiotherapy (SBRT) for liver metastases in patients not eligible for surgery.From 2000 to 2009, 74 patients with 91 liver metastases from different primaries have been treated with SBRT at our institution. Median planning target volume was 123 ccm (range: 10.6-1074 ccm). Treatment consisted of 3-5 fractions with 5-12.5 Gy/ fraction prescribed to the surrounding 60-95% isodose with daily image guidance. Regular follow-up included CT or MRI imaging until tumor progression.Median local recurrence-free interval was 23 months with a local control rate of 74.7%, 48.3% and 48.3% after 1, 2 and 3 years. Only minimum biologically effective dose (BED) to gross tumor volume (GTV) remained as independent significant factor for local control in multivariate analysis. No local recurrences were observed in lesions (n = 12) which received a minimal BED to the GTV of 120 Gy. Including 26 local recurrences, 67 patients (91%) showed disease progression after SBRT with a median time of 5 months. Median overall survival was 27 months with survival rates of 77%, 30% and 27% at 1, 3 and 5 years. On multivariate analysis only GTV volume remained as independent significant prognostic factor for overall survival (p = 0.002). No grade 3 to 5 acute toxicity and no grade 4 or 5 late toxicity occurred.SBRT for liver metastases was well tolerated in this non-selected patient cohort and yielded good local control despite the considerable size of most lesions treated. Long-term survival is possible after SBRT.
Authors with CRIS profile
Involved external institutions
Universität Rostock
Germany (DE)
Universitätsspital Basel
Switzerland (CH)
Technische Universität München (TUM)
Germany (DE)
Nordland Hospital / Nordlandssykehuset
Norway (NO)
Germany (DE)
Universitätsspital Basel
Switzerland (CH)
Technische Universität München (TUM)
Germany (DE)
Nordland Hospital / Nordlandssykehuset
Norway (NO)
How to cite
APA:
Andratschke, N.H.J., Nieder, C., Heppt, F., Molls, M., & Zimmermann, F. (2015). Stereotactic radiation therapy for liver metastases: factors affecting local control and survival. Radiation Oncology, 10, 69. https://doi.org/10.1186/s13014-015-0369-9
MLA:
Andratschke, Nicolaus H. J., et al. "Stereotactic radiation therapy for liver metastases: factors affecting local control and survival." Radiation Oncology 10 (2015): 69.
BibTeX: Download